SRS methods for untreated brain metastases under 4 cm
Part of Brain & nervous system, Cancer clinical trials.
This trial compares two stereotactic radiation strategies for patients who have intact (not previously radiated) brain metastases that are limited in size. It aims to see which approach works best in controlling the cancer while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have brain metastases that started from another body cancer (like lung, breast, or prostate)
- You have at least one untreated brain metastasis that is 2.0 to 4.0 cm on a recent contrast MRI
- You can have an MRI with contrast (dye) within 28 days
- You have not had whole-brain radiation before
- Your main brain metastasis is not larger than 4.0 cm, and it is not in the brainstem (if it is 2.0 cm or bigger)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares giving focused, high-precision radiation before or after surgery for brain metastases. It aims to see which timing works best to control tumors and improve outcomes.
This trial compares the usual short course of radiation therapy (one session) to a longer course (up to 5 sessions) for people with cancer that has spread to the brain. The goal is to see if the longer course works better and causes fewer side effects.
This study looks at how well your thinking and memory work after treatment with radiosurgery for brain metastases. It may help researchers understand which patients benefit best and how to monitor side effects on brain function.
This trial tests powerful, precisely aimed radiation (MR-guided stereotactic body radiation therapy) in a single session to treat 1 to 3 small metastatic tumors outside the brain and spine. It aims to control cancer growth with fewer visits and less impact on healthy tissue.
This trial compares two ways of giving radiation to the brain for people with 5 or more brain metastases: focused stereotactic radiosurgery, or a whole-brain approach that tries to spare the memory area (with memantine). It aims to see which method better protects thinking and memory while still treating the tumors.
This trial tests a local treatment approach (focused radiation) for people with multiple brain metastases. It may help by targeting several spots in the brain while keeping treatment within certain size and safety limits.
Hear when a new Metastatic Malignant Neoplasm in the Brain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.